VerImmune

VerImmune

Biotechnology

Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer

About us

VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer

Industry
Biotechnology
Company size
2-10 employees
Headquarters
Washington DC
Type
Privately Held
Founded
2019

Locations

Employees at VerImmune

Updates

Similar pages

Browse jobs

Funding